Searched for
NOVOVAX
View: A safe sub-unit protein vaccine will further enhance booster protection against Covid variantsEven when Omicron variants like BF.7 are exhibiting increased capacity for evading immunity, antibody surge from boosters may prevent sever...- SII will try to launch Omicron-specific vaccine after six months: Adar PoonawallaThe Pune-based Serum Institute is working with US biotechnology major Novavax to bring the Omicron-specific vaccine. Omicron sub-variant of...
- US envoy, Novovax CEO hail role played by India and SII during COVID-19 pandemicThe delegates noted the critical role played by US-India cooperation in addressing the COVID-19 pandemic and other global health challenges...
- Serum Institute gets USFDA nod to export Novavax covid jab to USThe USFDA approval makes SII - the first Indian vaccine maker to export vaccines to the US market, a testimony to the company's abilities t...
- India, US to facilitate joint research, information sharing to address global health challengesThe two countries have reaffirmed their commitment to facilitate joint research and information sharing to address barriers to pandemic-rel...
- Novavax applies for emergency use with WHO for its vaccine with SerumThe grant of EUL by the WHO is a prerequisite for exports to numerous countries participating in the COVAX Facility, established to allocat...
- Novovax, Serum Institute seek WHO's approval for their COVID vaccineThe Novavax shots are easier to store and transport than some other options. They've long been expected to play an important role in increa...
- WHO warns against mixing and matching COVID-19 vaccines"It's a little bit of a dangerous trend here. We are in a data-free, evidence-free zone as far as mix and match," Soumya Swaminathan told a...
- AMC jumps more than 18%, other 'meme stocks' mixedAMC’s shares were recently up 18.3% at around $58.50 after edging 3% higher last week. The company said in a filing last week that over 80%...
- Government body looking at mixed use of Covid-19 vaccines“This (taking the second dose of a different vaccine from the first dose) could vastly increase the flexibility of the national vaccine rol...
- Must extend side-effects monitoring to 28 days after vaccination: Top officialDr NK Arora, member of the national AEFI Adverse Events Following Immunization (AEFI) committee, said with more vaccines set to enter the m...
- Government hopeful of vaccinating entire adult population by DecemberA rapid scale-up of Covid-19 vaccine availability from next month should ensure the current crunch, particularly for the 18-44 age group, w...
- Serum’s launch of Novavax shot in India may face delayAdar Poonawalla had complained in the past that the manufacturing of the Novavax vaccine was getting delayed due to a shortage of raw mater...
- US export curbs can limit COVID-19 vaccine production, availability: SII CEO Adar PoonawallaSII, the world's biggest vaccine maker, has licensed the AstraZeneca/Oxford University product and will soon start bulk-manufacturing the N...
- Serum Institute of India plans to launch Covovax by June: Adar PoonawallaSII CEO Adar Poonawalla said on Saturday that its partnership for a Covid-19 vaccine with Novavax has shown excellent efficacy results. "We...
- Ukraine in talks with India on COVID-19 vaccine supply: Interfax"Negotiations are underway with an Indian manufacturer, Serum Institute, which can produce the American Novovax vaccine and has the ability...
- India bars Serum Institute of India from exporting AstraZeneca vaccineThe vaccine was granted emergency authorization by the Indian regulator on Sunday, but on the condition that Serum Institute doesn't export...
- Serum told to give Novavax Ph-2 trials dataPune-based vaccine maker SII had sought permission to conduct the bridging trial to the ongoing phase-3 clinical trial of American vaccine ...
- Germany expects COVID-19 vaccine in Q1 2021 at the earliestThe German government will cover the cost of the vaccines, while the cost of setting up the vaccination centres will be borne by the states...
- Covid-19: The frantic search for a cure continuesThough vaccine makers are jumping the usual loops of trial development, regulatory agencies are stepping in to ensure that the companies ar...
Load More
